3-Bromopyridine → 3-[2-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-phenyl]-pyridine
Reaction equation
[CH:1]1[C:11]2[CH2:10][CH2:9][C:8]3[CH:12]=[CH:13][CH:14]=[CH:15][C:7]=3[C:6](=[CH:16][C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=3B(O)O)[C:5]=2[CH:4]=[CH:3][CH:2]=1.Br[C:27]1[CH:28]=[N:29][CH:30]=[CH:31][CH:32]=1>>[CH:1]1[C:11]2[CH2:10][CH2:9][C:8]3[CH:12]=[CH:13][CH:14]=[CH:15][C:7]=3[C:6](=[CH:16][C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=3[C:27]3[CH:28]=[N:29][CH:30]=[CH:31][CH:32]=3)[C:5]=2[CH:4]=[CH:3][CH:2]=1Participants
3
Procedure
Following procedures essentially as described in Example 225 and using 2-(10,11-dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-phenylboronic acid (100 mg, 0.307 mmol) and 3-bromopyridine (73 mg, 0.460 mmol) provides the title compound. Purify further via silica gel chromatography to obtain 14.9 mg (14%) of material that is 98% pure by HPLC. MS (ES) 360 (M+H).
Sources & evidence
- ORD record
- ord-b2a3fe2a727746f6aedfc0de8a0a9600
- Source dataset
- uspto-grants-2008_08
- Patent number
- US07411072B2
Reaction notes
Loading…